|
Volumn 118, Issue 3, 2008, Pages 96-97
|
Updated guidelines for percutaneous coronary intervention: What are the most important changes?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
HEPARIN;
HIRULOG;
LOW MOLECULAR WEIGHT HEPARIN;
RAPAMYCIN;
ADD ON THERAPY;
ANGIOPLASTY;
ANTICOAGULATION;
CLINICAL PRACTICE;
DRUG ELUTING STENT;
EDITORIAL;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HUMAN;
LOADING DRUG DOSE;
ORGANIZATION;
PERCUTANEOUS CORONARY INTERVENTION;
PRACTICE GUIDELINE;
RECOMMENDED DRUG DOSE;
RISK BENEFIT ANALYSIS;
SMOKING CESSATION;
ST SEGMENT ELEVATION;
TREATMENT DURATION;
TREATMENT INDICATION;
|
EID: 41749087112
PISSN: 00323772
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (2)
|
References (7)
|